Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Tacrolimus, sold under the brand name Prograf among others, is an immunosuppressive drug. After an allogenic organ transplant, the risk of organ rejection is moderate; tacrolimus is used to lower the risk of organ rejection. Tacrolimus is also sold as a topical medication for treating T cell-mediated diseases, such as eczema and psoriasis. For example…
History, Applications & Research
Explore the main themes, entities and connections around Tacrolimus. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
drug also transplant rejection used liver topical risk use include kidney calcineurin macrolide molecule one enzyme cyp3a5 cancer name first
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Tacrolimus | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Tacrolimus | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Tacrolimus | ATC code | D11AH01 (WHO) L04AD02 (WHO) | 1.00 | infobox |
| Tacrolimus | Bioavailability | 24% (5–67%), less after eating food rich in fat | 1.00 | infobox |
| Tacrolimus | CAS Number | 104987-11-3 Y | 1.00 | infobox |
| Tacrolimus | ChEBI | CHEBI:61049 | 1.00 | infobox |
| Tacrolimus | ChEMBL | ChEMBL269732 Y | 1.00 | infobox |
| Tacrolimus | ChemSpider | 393220 Y | 1.00 | infobox |
| Tacrolimus | CompTox Dashboard (EPA) | DTXSID5046354 | 1.00 | infobox |
| Tacrolimus | DrugBank | DB00864 Y | 1.00 | infobox |
| Tacrolimus | ECHA InfoCard | 100.155.367 | 1.00 | infobox |
| Tacrolimus | Elimination half-life | 11.3 h for transplant patients (range 3.5–40.6 h) | 1.00 | infobox |
| Tacrolimus | Excretion | Mostly fecal | 1.00 | infobox |
| Tacrolimus | Formula | C44H69NO12 | 1.00 | infobox |
| Tacrolimus | KEGG | D08556 Y | 1.00 | infobox |
| Tacrolimus | KEGG | D00107 Y | 1.00 | infobox |
| Tacrolimus | Legal status | CA: ℞-only | 1.00 | infobox |
| Tacrolimus | Legal status | US: ℞-only | 1.00 | infobox |
| Tacrolimus | Legal status | EU: Rx-only | 1.00 | infobox |
| Tacrolimus | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Tacrolimus | License data | US DailyMed: Tacrolimus | 1.00 | infobox |
| Tacrolimus | MedlinePlus | a601117 | 1.00 | infobox |
| Tacrolimus | Metabolism | Liver CYP3A4, CYP3A5 | 1.00 | infobox |
| Tacrolimus | Molar mass | 804.031 g·mol−1 | 1.00 | infobox |
| Tacrolimus | Other names | FK-506, fujimycin | 1.00 | infobox |
| Tacrolimus | PDB ligand | FK5 (PDBe, RCSB PDB) | 1.00 | infobox |
| Tacrolimus | Pregnancy category | AU: C | 1.00 | infobox |
| Tacrolimus | Protein binding | ≥98.8% | 1.00 | infobox |
| Tacrolimus | PubChem CID | 445643 | 1.00 | infobox |
| Tacrolimus | Routes of administration | Topical, by mouth, intravenous | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.